论文部分内容阅读
目的:研究冠心病患者接受经皮冠状动脉介入治疗(PCI)围手术期焦虑状况,观察其疗效及安全性。方法:将68例冠心病行PCI术患者,予以术前及术后焦虑自评量表(SAS)评分,并将患者随机分为治疗组和对照组各34例,两组均接受常规治疗和PCI术,治疗组同时口服调心汤125 m L,采用SAS评分和临床资料调查表等,于治疗前后5 d进行评估分析。结果:治疗组患者手术成功率与对照组相同,治疗组焦虑明显缓解,差异具有统计学意义(P<0.05),治疗组患者临床疗效好于对照组,但差异无统计学意义(P>0.05),无明显并发症。结论:冠心病PCI围手术期患者使用中药调心汤,抗焦虑明显,可改善患者心绞痛症状,无明显副作用。
Objective: To study perioperative anxiety in patients with coronary heart disease undergoing percutaneous coronary intervention (PCI), and to observe its efficacy and safety. Methods: Sixty-eight patients with coronary artery disease undergoing PCI were enrolled in the study. The SAS scores were obtained preoperatively and postoperatively. The patients were randomly divided into treatment group (34 cases) and control group (34 cases) In the PCI group, the treatment group also received 125 m L of TXL, and the SAS score and clinical data questionnaire were used for assessment and analysis before and after treatment for 5 days. Results: The successful rate of operation in the treatment group was the same as that in the control group, and the anxiety in the treatment group was significantly relieved (P <0.05). The clinical efficacy of the treatment group was better than that of the control group, but the difference was not statistically significant (P> 0.05 ), No obvious complications. Conclusion: Coronary heart disease in perioperative patients with traditional Chinese medicine Tiaoxin Tang, anti-anxiety significantly, can improve the symptoms of angina patients without obvious side effects.